Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,897 | 51,615 | 4,207 | N/A | N/A |
| Marketable Securities | 82,219 | N/A | N/A | N/A | N/A |
| TOTAL | $106,026 | $51,808 | $4,242 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 48 | 8 | 9 | N/A | N/A |
| Other Non-Current Assets | 48 | 12 | 39 | 0 | 0 |
| TOTAL | $96 | $20 | $48 | $N/A | $N/A |
| Total Assets | $106,122 | $51,828 | $4,290 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 440 | 606 | 121 | 0 | 0 |
| Accrued Expenses | 1,225 | 331 | 51 | N/A | N/A |
| Other current liabilities | N/A | N/A | 1,003 | N/A | N/A |
| TOTAL | $2,724 | $1,524 | $1,302 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 216 | 230 | 4 | 0 | 0 |
| TOTAL | $216 | $230 | $4 | $N/A | $N/A |
| Total Liabilities | $2,940 | $1,754 | $1,306 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 974 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | 1 | 1 | N/A | N/A |
| Retained earnings | -40,889 | -12,883 | -4,110 | N/A | N/A |
| Other shareholders' equity | -100 | 60,756 | 6,711 | 0 | 0 |
| TOTAL | $103,182 | $50,074 | $2,984 | $N/A | $N/A |
| Total Liabilities And Equity | $106,122 | $51,828 | $4,290 | $0 | $0 |